Di Lullo et al. reported that the number of IL-22+IL-17−IL-13+ T cells is considerably augmented in peripheral blood and BM of stage III and relapsed/refractory MM subjects with respect to control subjects and subjects with asymptomatic or stage I/II disease. The gene discussed is IL22; the disease is Miyoshi myopathy.